8-K current report · filed Nov 3, 2026

UTAH MEDICAL PRODUCTS INC (UTMD) 8-K Current Report: November 3, 2026

Item 8.01Item 99.1Item EX-99.1UTMD overview

Short answer

UTAH MEDICAL PRODUCTS INC (UTMD) filed an 8-K current report with the SEC on November 3, 2026 reporting Item 8.01 (Other Events), Item 99.1 (), Item EX-99.1 (Exhibit EX-99.1). Quarterly cash dividend increased to $0.315 per share.

UTAH MEDICAL PRODUCTS INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • Quarterly cash dividend increased to $0.315 per share
  • Payment scheduled for January 5, 2027
  • Shareholder record date: December 17, 2026
  • Dividend increase signals greater cash-return commitment to shareholders

Item 99.1 ·

  • Filing contains only the 8-K signature block, with no substantive operating, financial, or strategic disclosure
  • CEO Kevin L. Cornwell signed the report on November 3, 2026

Item EX-99.1 · Exhibit EX-99.1

  • Quarterly dividend increased 1.6% to $0.315 per share
  • Payment scheduled January 5, 2027, for shareholders of record December 17, 2026
  • Dividend increase signals continued commitment to returning cash to shareholders
  • Recurring payout raises ongoing cash-flow obligations, though no broader capital-allocation changes announced

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other UTAH MEDICAL PRODUCTS INC 8-K filings

Get the next UTMD 8-K as it lands

Follow UTMD for push alerts, or ask the research agent what this filing means.